Age of the company
6 yearsCapital in CHF
10,1 Mio.Active brands
0Address
Avenue Giuseppe-Motta 31-37
1202 Genève
Reports for Commave Therapeutics SA
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company. Find out moreEconomic information
Comprehensive information about the economic situation of a company. Find out morePayment collection information
Overview of current and past debt enforcement proceedings. Find out moreCompany dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data. Retrieve company dossierAbout Commave Therapeutics SA
- Commave Therapeutics SA with its legal headquarters in Genève is active. Commave Therapeutics SA operates in the sector «Operation of investment companies».
- Commave Therapeutics SA has 5 persons entered in its management.
- All modifications to the commercial register entry can be found under «Notifications». The most recent modification was made on 23.04.2024.
- The reported UID is the following: CHE-377.777.355.
- The address is identical with 17 other active companies. These include: Auregen BioTherapeutics SA, B-FLEXION 1686 Partners Holding SA, B-FLEXION Advisors (Switzerland) SA.
Management (5)
newest board members
Nicolas Schnyder,
Giampiero De Luca,
Stefan Mario Meister,
Frédéric Yves Boder
newest authorized signatories
Nicolas Schnyder,
Grégory Deballe,
Giampiero De Luca,
Stefan Mario Meister,
Frédéric Yves Boder
Commercial register information
Entry in the commercial register
19.12.2017
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Genève
Commercial Registry Office
GE
Commercial register number
CH-660.3.815.017-0
UID/VAT
CHE-377.777.355
Sector
Operation of investment companies
Purpose (Original language) Customise the company purpose with just a few clicks.
Prise de participations dans des sociétés suisses ou étrangères, acquisition, vente, détention et gestion de titres de participations, de licences, de brevets ou de tout autre droit, et de produits pharmaceutiques (y compris de produits à développer), à l'exclusion de toute opération prohibée par la LFAIE (cf. statuts pour but complet).
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Ernst & Young SA | Lancy | 22.03.2021 | ||
Other company names
Past and translated company names
- BOSTON PHARMACEUTICALS HOLDINGS SA
Ownership structure
Holdings
Newest SOGC notifications: Commave Therapeutics SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006016029, Commercial Registry Office Geneva, (660)
Commave Therapeutics SA, à Genève, CHE-377.777.355 (FOSC du 21.04.2023, p. 0/1005729882). Lacour Gilles n'est plus administrateur;
ses pouvoirs sont radiés. Schnyder Nicolas, de Schüpfheim, au Grand-Saconnex, est membre du conseil d'administration avec signature collective à deux.
Publication number: HR02-1005729882, Commercial Registry Office Geneva, (660)
Commave Therapeutics SA, à Genève, CHE-377.777.355 (FOSC du 03.04.2023, p. 0/1005716032). Procuration collective à deux a été conférée à Deballe Grégory, de France, à Divonne-les-Bains, FRA.
Publication number: HR02-1005716032, Commercial Registry Office Geneva, (660)
Commave Therapeutics SA, à Genève, CHE-377.777.355 (FOSC du 28.10.2022, p. 0/1005593435). Kornowski Sophie et Sternberg Perry ne sont plus administrateurs;
leurs pouvoirs sont radiés.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.